Curriculum Vitae

EDUCATION:

1967-1971 Portsmouth High School
1971-1975 Dartmouth College (A.B. cum laude)
1976-1978 Universidad del Noreste School of Medicine (Tampico, Mexico)
1978-1980 Dartmouth Medical School (M.D. with honors)

POSTDOCTORAL TRAINING:

Fellowships and Residencies

Albany Medical Center and affiliated hospitals:
1980-1982 Internal Medicine intern/resident

Dartmouth-Hitchcock Medical Center:
1982-1984 Resident in Neurology
1984-1985 Chief Resident in Neurology

LICENSURE AND CERTIFICATION:

New York (inactive)
Vermont (1989 #42-0007986)
New Hampshire (1985-2023 #7049) (inactive)

Diplomate National Board of Medical Examiners 1981

Diplomate American Board of Psychiatry and Neurology 1986 Certificate Number 28832

2001 Certificate of Added Qualification by the National Board for Certification in Headache Management (Certificate Number 005)

Subspecialty Certificate in Headache Medicine (United Council for Neurologic Subspecialties) (ID#MRA9122221011, Certificate Number HM00300-06) September 30, 2006

Subspecialty Certificate in Headache Medicine (Certificate Number HM00845-16) (recertification) granted October 31, 2016 for a period of 10 years. I have chosen not to participate in the newly-initated
ongoing recertification process.

ACADEMIC APPOINTMENTS:

1981-1982, Instructor in Medicine – Albany Medical College
1984-1985, Instructor in Clinical Medicine – Dartmouth Medical School
1985-1990, Adjunct Assistant Professor of Clinical Medicine, Dartmouth Medical School
1990-1999, Assistant Professor of Medicine (Neurology) – Dartmouth Medical School
1999-2006, Associate Professor of Medicine (Neurology) – Dartmouth Medical School
2006-2009, Professor of Medicine (Neurology) – Dartmouth Medical School
2009-2016, Professor of Neurology – Dartmouth Medical School
2016-Present, Active Emeritus Professor of Neurology Geisel School of Medicine at Dartmouth

HOSPITAL APPOINTMENTS:

1985-1989, Medical Staff, Lakes Region General Hospital, Laconia, NH
1985-1992, Courtesy Consulting, Franklin Regional General Hospital, Franklin, NH
1985-1989, Consulting Staff, Huggins Hospital, Wolfeboro, NH
1989-1994, Outreach, Staff Physician, North Country Hospital, Newport, VT
1989-1993, Consulting Neurologist, Northeastern Vermont Regional Hospital, Inc., St. Johnsbury, VT
1989-1999, Consulting Neurologist, Speare Memorial Hospital, Plymouth, NH
1990-2003, Consulting Neurologist, Gifford Memorial Hospital, Randolph,VT
1989-2008, and 2019-Present, Consulting Neurologist, Veterans Administration Hospital, White River Jct., VT

OTHER PROFESSIONAL POSITIONS:

1985-1989, Neurologist, Laconia Clinic, Laconia, NH
1989-2016, and 2018, Neurologist, Hitchcock Clinic, Lebanon, NH
1992-1998, Director, Headache Clinic, Dartmouth-Hitchcock Medical Center, Lebanon, NH (Co-Director, with Dr. Morris Levin, since 1998 until 2014).
2008-2016, Senior Member, Hitchcock Clinic, Lebanon, NH
2014-2016, Director, Headache Clinic Dartmouth-Hitchcock Medical Center, Lebanon, NH
2014-2016, Director, Headache Fellowship Program, Dartmouth-Hitchcock Medical Center, Lebanon, NH
2016-Present, President and Treasurer, Dartmouth Region Medical Legal Consulting.

MAJOR COMMITTEE ASSIGNMENTS AND CONSULTATIONS:

National/International:

American Headache Society –

Constitution and Bylaws Committee 1991-1996
Awards Committee 1992-1996
Board of Directors 1996-2000
Chairman Electronic Media Committee 1996-1999
Ethics Committee 2000-2002
Research Review Board 1998-2000, 2002-2006
Electronic Media Committee 2006-2010
Awards Committee 2013-2020
Publications Committee 2010-2020
Exhibit Committee (Chair) 2020-Present
Nominating Committee 2012-2019 and 2020-Present

Board of Directors (ex officio as editor-in-chief of the journal) 2013-2020

International Headache Society – Scientific Program Committee for the IHC 2019 in Dublin, Ireland

American Academy of Neurology –

Chair, Section of Headache and Facial Pain 2001-2003
Chair, Harold Wolff-John Graham Award Subcommittee 2003-2009

National Board for Certification in Headache Management 2000-2006 (President 2002-2004)

Regional:

Headache Cooperative of New England

Board of Directors 1992-Present
Secretary 1992-1997
Treasurer 2007-2018
President 2018-Present

New Hampshire-Vermont Neurologic Society President 1994-1995

Institutional:

Dartmouth –

Committee for the Protection of Human Subjects (Dartmouth College) Member 1995-1997 Alternate Member 1998-2004
Dartmouth Medical School Admissions Committee 2003-2006
2005-2011, Faculty Program Course (RSS) Director Weekly Neurology CME Grand Rounds
2007-2009, Section of Neurology Executive Committee
2009-2016, Department of Neurology Executive Committee
2009-2016, Department of Neurology Promotions Advisory Committee
2011-2012, Chairman of Committee for the Protection of Human Subjects D and B panels.
2011-2012, Dartmouth College Conflict of Interest Committee
2020-Present, Diamond Endowment Project Review Committee (with Dr. James Bernat)

MEMBERSHIP, OFFICE & COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES:

1985-1999, American Medical Association

1989-Present, Northern New England Neurologic Society (formerly known as the NH-VT Neurologic Society)

1982-Present, Member
1994-1995, President
1995-1997, Past President

1985-1989, Belknap County Medical Society

1985-Present, New Hampshire Medical Society

2017-Present, Vermont Medical Society

1990-Present, American Association for the Study of Headache (now known as the American Headache Society)

1991-1996, Constitution and Bylaws Committee
1992-1996, AASH Awards Committee
1996-2000, Board of Directors (Member at Large)
2013-2020 Board of Directors ex officio, as Editor-in-Chief of the Society’s journal
1996-1999, Chairman, Electronic Media Committee (reports to Education Committee)
1996-1999, Neurology Resident Training Sub-Committee
1999-Present, Neurology Resident Training Sub-Committee, Chairman
1998-2000, Educational Advisory Board
1998-2000, 2002-2004, Research Review Board
2000-2002, Ethics Committee
2006-2009, Electronic Media Committee
2010-2020, Publications Committee
2012-2019, Nominating Committee and 2020-Present
2020-Present, Exhibit Committee (Chair)
2013-2020 Editor-in-Chief, Headache: The Journal of Head and Face Pain

1991-Present, International Headache Society, Member

1992-Present, Headache Consortium of New England (now known as the Headache Cooperative of New England)

1992-1997, Secretary
1992-Present, Member, Board of Directors
2000-2008, Chair, Nominating Committee
2007-2008, Treasurer
2018-Present, President

1992-2000, Governing Body of American Council for Headache Education (ACHE)

1993-2007, The Movement Disorder Society

1983-Present, American Academy of Neurology:

1994-Present, Section of Headache and Facial Pain
1995-1999, Secretary of the Section of Headache and Facial Pain
1999-2001, Chair-elect Section of Headache and Facial Pain
2001-2003, Chair, Section of Headache and Facial Pain
1995-2014, Section of Movement Disorders
1996-2000, Sub-committee for Website Content (Section of Headache & Facial Pain)
2003-2009, Chair, Harold Wolff-John Graham Award Subcommittee
2017-2018, Topic Work Group
2018-2019, Topic Work Group

1994-2010, National Headache Foundation

2000-2006, National Board for Certification in Headache Management

2000-2002, Vice President
2002-2004, President
2004-2006, Past President
Certified February 2001 Certificate Number 005

2009-Present, American Neurological Association

Active member (elected)
2012-Present, Fellow American Neurological Association

EDITORIAL BOARDS:

2004–2012, Associate Editor, Headache
2009-2012, Editor, Headache Currents
2013-2020, Editor-in-Chief, Headache: The Journal of Head and Face Pain

AWARDS AND HONORS:

1980 – Alpha Omega Alpha Honor Medical Society (AOA): Dartmouth
1980 – Sandoz Neurology Award
1980 – MD with honors (Dartmouth Medical School)
1994, 1998, 2001-2014 Best Doctors in America
1995 The American Council for Headache Education Professional Recognition Award – Boston, MA
1996 Fellow, American Academy of Neurology
2000 Dystonia Doctor of Excellence Award, Dystonia Medical Research Foundation (Chicago, Illinois)
2001 Certificate of Added Qualification by the National Board for Certification in Headache Management (Certificate Number 005)
2003 – Fellow, American Headache Society
2004 – Arnold P. Friedman Distinguished Clinician Award (American Headache Society)
2014 – November 12, 2014. Visiting Headache Scholar, John R. Graham Headache Center, Faulkner Hospital, Boston MA.
2017 – Lifetime Achievement Award. Headache Cooperative of New England. April 1, 2017, Stowe, Vermont.
2020 – Distinguished Service Award. American Headache Society.

JOURNAL REFEREE ACTIVITIES:

Reviewer for:

1994 – Headache: the journal of head and face pain
1997 Spine
1997 Journal of Neuromuscular System
2002-2003 Archives of Neurology
1997-2003, 2010, 2018 Abstract reviewer for Annual Meeting for American Academy of Neurology
2002-2018 Cephalalgia
2003-2006 Headache Quarterly
2003 American Journal of Drug Delivery
2004, 2006-2020 Neurology
2004-2005 European Journal of Neurology
2005-2006 Expert Review of Neurotherapeutics
2006 Neuropsychiatric Disease and Treatment
2007 Abstract reviewer for the Annual Scientific Meeting of the American Headache Society
2010, 2011 Abstract reviewer for the American Neurological Association meeting
2012 Brain
2020 – 2021 JAMA Neurology

Other Activities:

1985-1989 Neurologist, Laconia Clinic, Laconia, NH
1986-1989 Quality Assessment Committee, Matthew Thornton Health Plan, Laconia Clinic
1989- Neurologist, Mary Hitchcock Memorial Hospital, Hanover/Lebanon, NH
1985-1989 Lakes Region General Hospital Bioethics Committee
1985-1989 Board of Directors, Lakes Region Mental Health Center, Laconia, New Hampshire
1987-1989 Ad Hoc Organ Transplant Committee, Lakes Region General Hospital
1997 – Delegate to World Headache Alliance, Amsterdam, The Netherlands
10/10/98 Panel member for Clinical and Therapeutic Advances in Migraine Management: A Managed Care Perspective. Coronado, CA. In the American Journal of Managed Care, 1999 Vol. 5, No. 2, Suppl.
5/10/12-5/12/12 International Headache Society Masters School. Guarulhos, SP Brazil.
2018-2019 International Headache Society Scientific Programme Committee for the 2019 International Headache Congress, Dublin, Ireland.
2021-2022 Data Safety Monitoring Board for IND-151376. A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headaches. AEN Biopharma, Inc.
2022 Guest Co-editor (with Laine Green) Seminars in Neurology Update on Headache.

MAJOR RESEARCH INTERESTS:

Headache

Movement Disorders — botulinum toxin

RESEARCH FUNDING:

Past:

A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Injectable DHE-45 and Injectable Sumatriptan in the Acute Treatment of Classic and Common Migraine. In association with LR Jenkyn and DJ Coffey and Sandoz Inc.Feb. 93 to Mar. 94. (Local principal investigator)

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Sumatriptan Suppositories in the Acute Treatment of Three Migraine Attacks. In association with LR Jenkyn, DJ Coffey and Glaxo Inc. Oct. 93 to July 94. (Local principal investigator)

A Phase IV, Parallel, Double-Blind, Randomized, Single Dose Study Comparing the Analgesic Efficacy and Safety of Acetaminophen 1000 mg, Naproxen Sodium 440 mg and Placebo in the Treatment of Tension Headache. In association with LR Jenkyn, DJ Coffey and McNeil Consumer Products Company, Oct. 93 to May 94. (Local principal investigator)

A Randomized, Double-Blind, Placebo- Controlled Study to Evaluate Headache Pain Relief with Sumatriptan Nasal Spray (5mg, 10mg and 20mg) Across Three Migraine Attacks. In association with LR Jenkyn, DJ Coffey and Glaxo Inc. July 94 to Jan 95. (Local principal investigator)

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Confirm the Efficacy and Safety of 311C90 in the Treatment of Acute Migraine Headache. In association with LR Jenkyn, DJ Coffey and Burroughs Wellcome Co. Jan 95 to July 95. (Local principal investigator)

Protocol for a Multicenter, Open Study to Investigate the Long Term Effects of Oral 311C90 in the Treatment of Migraine Headache. In association with LR Jenkyn, DJ Coffey and The Wellcome Foundation LTD. Feb 95 to March 96. (Local principal investigator)

A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effectiveness and Safety of Migramist® (Dihydroergotamine Mesylate Nasal Spray) 2 mg for the Acute Treatment of Migraine Headache with or without Aura in Migraineur Families. In association with LR Jenkyn, DJ Coffey and Sandoz Pharmaceuticals Corp. Jan 95 to December 95. (Local principal investigator)

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of 25mg, 50mg and 100mg Oral Sumatriptan in Adolescent Migraine Subjects. In association with LR Jenkyn, DJ Coffey and Glaxo Inc. Jan 95 to Feb 96. (Local principal investigator)

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Oral Naratriptan in the Acute Treatment of Four Migraine Attacks. In association with LR Jenkyn, DJ Coffey and Glaxo Inc. May 95 to March 96. (Local principal investigator)

A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Confirm the Efficacy and Safety of a 2.5 mg Dose of 311C90 in the Acute Treatment of Migraine Headache. In association with LR Jenkyn, DJ Coffey and Burroughs Wellcome Co. November 95 to March 96. (Local principal investigator)

A Double-Blind Randomized Trial of Three Fixed Doses of BMS-180048 and Placebo in the Treatment of Patients with Migraine. In association with LR Jenkyn, DJ Coffey and Bristol-Myers Squibb Co. May 95 to November 95. (Local principal investigator)

A Long Term Safety and Efficacy Trial of BMS-180048 in the Treatment of Acute Migraine Attacks. In association with LR Jenkyn, DJ Coffey and Bristol-Myers Squibb Co. October 95 to January 96. (Local principal investigator)

Randomized, Double-Blind Trial Comparing the Safety and Efficacy of Butorphanol Tartrate Nasal Spray Versus Acetaminophen and Codeine Phosphate Capsules Versus Placebo in Patients with Acute Migraine Headache Pain. In association with LR Jenkyn, DJ Coffey and Bristol-Myers Squibb Co. October 95 to March 96. (Local principal investigator)

Electronic Recurrent Visual Analog Scale: Pilot Project. In association with LR Jenkyn, DJ Coffey and Bristol-Myers Squibb Co. October 95 to February 96. (Local principal investigator)

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center, Single-Dose, Dose-Range-Finding Study of VML 251 in the Acute Treatment of Migraine. In association with LR Jenkyn, DJ Coffey and Vanguard Medica. February 96 to August 96. (Local principal investigator)

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Study of the Efficacy and Safety of Oral Eletriptan with Acute Migraine. In association with LR Jenkyn, DJ Coffey and Pfizer Inc. July 1996 to July 1997. (Local principal investigator)

A Multicenter, Randomized, Open Label, Comparative, Study of the Safety, Toleration and Efficacy of Oral Eletriptan for Long Term Treatment of Subjects with Acute Migraine. In association with LR Jenkyn, DJ Coffey and Pfizer, Inc. August 96 to July 98. (Local principal investigator)

A Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability and Safety of Galantamine (GAL-USA-1) in the Treatment of Alzheimer’s disease. In association with LR Jenkyn, DJ Coffey, M Chang, TJ Lukovits and Janssen Research Foundation. October 96 to October 97.

A Multicenter, Long Term Study to Maximize Migraine Relief with 311C90 (MAXIMM). In association with LR Jenkyn, DJ Coffey and Zeneca Pharmaceuticals Inc. November 96 to January 98. (Local principal investigator)

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Dose-Range-Finding Study to Assess the Efficacy, Tolerability and Safety of VML 251/96/14 (administered as a single dose of 0.5 mg, 1.0 mg, 2.5 mg, or 5.0 mg) in the Acute Treatment of Migraine. In association with LR Jenkyn, DJ Coffey and Vanguard Medica. February 97 to July 97. (Local principal investigator)

A Randomized, Double-Blind Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Oral Naratriptan for Treatment of Migraine Headache. In association with LR Jenkyn, DJ Coffey and Glaxo, Inc. August 1997 to 1999 (Local principal investigator).

A Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Three Dose levels (5 mg, 10 mg, 20 mg) of Sumatriptan Nasal Spray in the Acute Treatment of a Single Migraine Headache in Adolescents Migraineurs (12-17 years of age). In association with LR Jenkyn, DJ Coffey and Glaxo Inc. October 97 to November 98. (Local principal investigator)

An Open-Label Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Sumatriptan Nasal Spray in the Acute Treatment of Multiple Migraines Headache in Adolescent Migraineurs (12-17 years of age). In association with LR Jenkyn, DJ Coffey, and Glaxo, Inc. October 97 to November 99. (Local principal investigator)

A Single Dose, Double Blind, Dose Ranging, Placebo-Controlled Safety and Efficacy of Various Doses of Naproxen Sodium and Metoclopramide in Subjects with Acute Migraine Headaches. In association with LR Jenkyn, DJ Coffey and Pozen Inc. August 1997 to August 1998. (Local principal investigator)

A Randomized, Double-Blind, Double-Dummy, Active-Placebo Controlled, Parallel Group Evaluation of Oral Naratriptan (2.5mg) Compared to Oral Naproxen Sodium (275mg) on Migraine-Related Quality of Life. In association with LR Jenkyn, DJ Coffey and Glaxo Wellcome. September 1997 to May 1998. (Local principal investigator)

A Randomized. Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Efficacy of Oral Naratriptan (2.5 mg) for the Treatment of Migraine in Subjects who do not Respond to Oral Sumatriptan (50mg). In association with LR Jenkyn, DJ Coffey and Glaxo Wellcome, Inc. October 1997 to June 98. (Local principal investigator)

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of Two Doses of BOTOX® (Botulinum Toxin, Type A) Purified Neurotoxin Complex for the Prophylactic Treatment of Chronic Migraine Headaches. In association with RM Richardson, MD and Allergan. February, 98 to September, 98. (Local principal investigator)

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Clinical Study of the Safety and Efficacy of BOTOX® (Botulinum Toxin, Type A) Purified Neurotoxin Complex Comparing Different Muscle Injection Areas for the Prophylactic Treatment of Migraine Headaches. In association with M. Levin MD, RM Richardson, MD and G Greenough,MD and Allergan, November, 98 to December, 99. (Local principal investigator)

A Randomized, Open-Label, Two-Period Crossover Study Comparing Preference for Rizatriptan MLT 10 mg or Sumatriptan 50 mg Tablet for the Acute Treatment of Migraine. In association with Morris Levin MD and Merck & Co., Inc., December, 1999 to April, 2000.

An Open-label Long-term Observational Study of the Safety and Tolerability of Sumatriptan Nasal Spray in the Treatment of Migraine in Adolescents. In association with Morris Levin and Glaxo Wellcome, Inc. May, 2000-October, 2001. (Local principal investigator).

A Multicenter, 2 –phase, Double-blind, Randomized, Placebo-controlled, Parallel Trial to Evaluate the Efficacy and Tolerability of the Zolmitriptan (Zomig®) 2.5-mg Orally Disintegrating Tablet When Taken As Soon As Possible After the Onset in the Acute Treatment of Migraine Headache. In association with Morris Levin MD and AstraZeneca LP. December 2000-2001(Local principal investigator).

A Multicenter, Randomized, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate the Efficacy and Tolerability of the Zolmitriptan (Zomig®) 5-mg Orally Disintegrating Table in the Acute Treatment of Adult Subjects with Migraine Headache. In Association with Morris Levin MD and AstraZeneca LP. December 2000- 2001 (Local principal investigator).

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Botox® (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Headaches in the Chronic Headache Population. In association with Morris Levin MD and Allergan, Inc. July 2001- 2002 (Local principal investigator)

A Double-Blind, Placebo-Controlled, Three-Way Cross-Over Clinical Study to Assess the Safety and Efficacy of Two Dose Regimens of Frovatriptan, Compared with Placebo, in Preventing Menstrually-Associated Migraine (MAM) Headache. (Local principal investigator with Dr. Morris Levin and Elan) 2001-2002

A Multicenter, 2-phase, Double-blind, Randomized, Placebo-controlled, Parallel Trial to Evaluate the Efficacy of a Single Dose of Zolmitriptan (Zomig ®) as Acute Treatment in Phase I and Repeated Doses as Preemptive Treatment in Phase II for Menstrual Migraine Headache. (Local principal investigator with AstraZeneca).July 2001-June 2002

A Phase III, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache. (Local principal investigator with Dr. Morris Levin and Winston Laboratories). February 2002-2003.

A Multi-center, Randomized, Placebo-controlled, Parallel-group Trial to Evaluate Early Efficacy and Tolerability of Zolmitriptan (Zomig®) Nasal Spray in the Acute Treatment of Adult Subjects with Migraine. (Local principal investigator with Dr. Morris Levin and AstraZeneca). November 2002-2003

A Double-Blind, Multi-Center, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of Trexima™ in the Acute Treatment of Migraine Headaches. (Local principal investigator with Dr. Morris Levin and Pozen, Inc.) October 2004- 2005.

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 in Migraine Prophylaxis (Local principal investigator with Dr. Morris Levin and Esai Medical Research, Inc) November 2004- October 2005.

An Open-Label Safety and Immunogenicity Study of Myobloc (Neurobloc: Botulinum Toxin Type B) Injectable in Patients with Cervical Dystonia. December, 2001- 2006 (Local principal investigator with Dr. Jeffrey Cohen and Solstice, Inc.)

A Multi-Center, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Tablet for the Treatment of Menstrual Migraine (Local principal investigator with Drs. Lee Peterlin and Morris Levin and Merck and Co. Inc.). July 2005-February 2006.

Headache in Transgendered Individuals. In association with Dr. Lee Peterlin (local PI) and Dr. John Turco. January 2005-January 2007

A Prospective, Multi-Center, Double-Blinded, Placebo-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure with the Starflex® Septal Repair Implant to Resolve Refractory Migraine Headache with Aura. (Local PI in association with Drs. Aaron Kaplan, Morris Levin, Timothy Lukovits and Syed Arshad, and NMT Medical, Inc.). January 2007-February 2008

Intravenous levertiracetam in the acute treatment of migraine: a prospective, randomized, double-blind pilot study. Local PI in association with Dr. Alan Rapoport (Co-PI), and Morris Levin MD and Jean-Anne Brown ARNP. Grant support from UCB Pharma. 2007-2008

2003 – Center of Excellence 2 year grant ($50,000 annually) with Dr. Morris Levin from Allergan to be used for research/teaching involving botulinum toxin and pain.

Phase III Research Evaluating Migraine Prophylaxis Therapy with Botulinum Toxin Type A. In association with Dr. Morris Levin (local PI) and Allergan, Inc. January 2006-July 2008

Inflammatory Markers in Migraine – Ictally and Interictally. Local PI in association with Dr. B. Lee Peterlin (PI) and Drs. Morris Levin, Gretchen Tietjen, Wayne Cooper and Glaxo Wellcome. 2010-201

Electronic Recurrent Visual Analog Scale: Pilot Project. In association with LR Jenkyn, DJ Coffey and Bristol-Myers Squibb Co. October 95 to February 96. (Local principal investigator)

Headache in Transgendered Individuals. In association with Dr. Lee Peterlin (local PI) and Dr. John Turco. January 2005-January 2007

2003 – Center of Excellence 2 year grant ($50,000 annually) with Dr. Morris Levin from Allergan to be used for research/teaching involving botulinum toxin and pain.

Phase III Research Evaluating Migraine Prophylaxis Therapy with Botulinum Toxin Type A. In association with Dr. Morris Levin (local PI) and Allergan, Inc. January 2006-July 2008

Inflammatory Markers in Migraine – Ictally and Interictally. Local PI in association with Dr. B. Lee Peterlin (PI) and Drs. Morris Levin, Gretchen Tietjen, Wayne Cooper and Glaxo Wellcome. 2010-2011

TEACHING EXPERIENCE/CURRENT TEACHING RESPONSIBILITIES:

Dartmouth Medical School:

1994-2003, Preceptor – Longitudinal Clinical Experience (now called “On Doctoring”)
1990-1998, DMS II SBM annual lectures on Headache, Multiple Sclerosis/Degenerative Diseases and CPCs
2002, and 2014 DMS II (SBM) Pharmacologic therapy of headache.
2004-2015 DMS II (SBM) Headache
2000-2012 DMS II SBM Neurology CPCs

Dartmouth Hitchcock Medical Center:

1990-1998, 2003-2014 Annual DHMC Housestaff Lecture on Headache
2-4 week Neurology Clerkship rotations 1990-2000
1996 Mini-Fellowship – Dr. Richard Whiting
1998 Mini-Fellowship – Dr. David Russo
2001 Mini-Fellowship – Dr. Francisco Umana

Neurology Residents’ Clinic Supervision:

2000-2015. Monthly headache lecture to interns and medical students on the neurology service
2000-2016. Lectures on headache to DHMC Pain Clinic (annually to Pain Fellows and Attendings).
2006- 2015. Annual review on Headache to Psychiatry residents.

Headache Fellow Supervision/Teaching:

2001-2002 Dr. Avi Ashkenazi
2004-2005 Dr. B. Lee Peterlin
2014-2015 Dr. Barbara Nye
2015-2016 Drs. Jihan Grant and Richard Kim

Introductory headache lectures to incoming headache fellows:

July/August 2016 (Drs. Iryna Aberkorn, Benjamin Saunders)
July 2017 Dr. Nicholas Tzikas
July 2018 Dr. Amanda Macone
July 2019 Drs. Michael Yang and Mark Youseff
July 2020 Drs. Naveen George, Ioana Medrea
July, 2021. Drs. Anna Odermann and Istvan Tomaschek
July 18, 2022 Drs. Diana Li and Jessica Abreu

Pain Fellow Teaching in Headache Clinic at DHMC. Every Tuesday morning 8am to 11am. 2006-2016

Faculty Program Course Director Weekly Neurology CME Grand Rounds 2005-2011

March 21, 2017, Lecture to neurology residents on peer review.

October 29, 2018. Lecture to neurology residents on optimizing chances of academic publication.

Regional:

Headache Consortium of New England (now known as the Headache Cooperative of New England) Annual meetings at Stowe, VT, and Boston, MA.

National:

1994-1996 Faculty Osler Institute
1993-1995 National Faculty Core Conference Review of Family Practice
2000-2005. Neurology Ambassadors’ Program Faculty

INVITED PRESENTATIONS:

Regional:

March 9, 1990 – Neurology Grand Rounds; Dartmouth Hitchcock Medical Center, Discussion of Motor Neuron Diseases and Chronic Inflammatory Demyelinating Polyradicular Neuropathy

1991 Cluster Headaches – Neurology Grand Rounds DHMC – Lebanon, NH

1992 Migraine Headaches and Treatment – Neurology Grand Rounds DHMC – Lebanon, NH

1991-Analgesic Rebound Headaches – NH State Medical Society, Portsmouth, NH

1990-2004 Headache Diagnosis and Treatment – Neurology for the Non-Neurologist – Annual Dartmouth Hitchcock Medical Center CME program – Woodstock, VT

9/24/94 – CT Update on Headache & Neck Pain – Indomethacin-responsive headaches – Meriden, CT

11/10/94 – Ground Rounds – Pathophysiology of Headache Elliott Hospital Manchester, NH

2/1/95 – Headache Pathophysiology – Grand Rounds – CMC – Manchester, NH

September 30, 1995 Diagnosis and Treatment of Migraine – New England Osteopathic Association – Hyatt Regency, Cambridge, MA

February 28, 1996 Headache: Mechanism and Treatment – St. Peter’s Hospital, Albany, NY

April 14, 1996 Cluster Headache and Indomethacin – responsive Headaches: Mechanisms, Diagnosis and Treatment Options – New York Headache Foundation

July 19, 1997 Pharmacologic Treatment of Chronic Headache & Treatment of an Acute Severe Headache – Lahey-Hitchcock Clinic Headache Conference – Nashua, NH

August 17-20, 1997 Keynote lecture on: The Difficult Headache Patient- also two workshops on Intractable Headache and Facial Pain – UVM, Burlington, VT

October, 1997 Epidemiology and Co-morbidity of Headache – (Colonnade Hotel) Harvard University, Boston, MA

November 17, 1997 Past, Present and Future Treatment of Migraine – CT Neurologic Society – Danbury, CT

November 25, 1997 Future Migraine Treatment – CT Headache Update – Cromwell, CT

February 26, 1998 Headache Pathogenesis and Treatment – Albany Medical Center – Neurology Grand Rounds, Albany, NY

September 15, 2000 Headache Evaluation and Treatment – VA Hospital, Bedford, MA

October 14, 2000 New Frontiers in Headache Treatment – Headache Cooperative of New England – Greenwich, CT

November 11, 2000 State of the Art Migraine Diagnosis and Treatment – Headache Cooperative of New England – Teaneck, NJ

January 12, 2001 Chronic Daily Headache – Dartmouth-Hitchcock Medical Center- Section of Behavioral Medicine – Lebanon, NH

March 3, 2001 Acute and Preventative Treatment of Headache – Headache Cooperative of New England – Stowe, VT

April 20, 2001 Botulinum Toxin: Deadly Poison to Therapeutic Triumph Dartmouth-Hitchcock Medical Center, Department of Medicine Grand Rounds – Lebanon, NH

October 6, 2001 Headache Treatment in the 21^st Century – Headache Cooperative of New England – Old Greenwich, CT

October 24, 2001 Early Intervention Treatment in Migraine – St. Joseph Hospital, Nashua, NH

October 25, 2001 Stratified Care vs. Step Care in the Treatment of Migraine. Sponsored by Dartmouth-Hitchcock Medical Center. Four Seasons Hotel, Boston, MA

October 26, 2001 Headache Diagnosis and Management – Lahey Clinic, Boston, MA.

November 10, 2001 Acute and Preventative Treatment of Migraine – Headache Cooperative of New England – Boston, MA

February 3, 2002 Headache Disability – A Focus on Migraine and its Treatment – New England Pain Association – Woodstock, VT

March 22, 2002 Botulinum toxin utilized for dystonia – Northern New England Neurologic Society – Stowe, VT

April 28, 2002 Prophylactic Therapies – New York Headache Foundation, 14^th Annual Symposium – New York, NY.

June 5, 2002. Optimal Management of Acute Primary Headaches – Sceva Speare Memorial Hospital Grand Rounds – Plymouth, NH

September 25, 2002 – 21^st Century Migraine Management – Weeks Memorial Hospital Grand Rounds – Lancaster, NH

October 22, 2002 Post-traumatic Headaches: Evaluation and Management – Boston University Medical Center – Boston, MA

October 26, 2002 State of the Art Headache Treatment – Headache Cooperative of New England -Boston, MA

November 20, 2002 Maximum Impact Headache Treatment – New London Hospital Grand Rounds – New London, NH

November 23, 2002 Migraine Recognition and Treatment – PrimaryCareNet – Albany, NY

December 7, 2002 Migraine Recognition and Treatment – PrimaryCareNet – Portland, ME

January 10, 2003 Acute and Preventative Therapy of Migraine. Dartmouth-Hitchcock Medical Center. Managing Headache in Primary Care. Lebanon, NH

January 10, 2003 Chronic Daily Headache. Dartmouth-Hitchcock Medical Center. Managing Headache in Primary Care. Lebanon, NH

January 12, 2003 Therapy of Migraine – Physician Assistant Academy of Vermont. Stowe, VT

January 31, 2003 Post-traumatic Headaches – Neurology Grand Rounds, Dartmouth Hitchcock Medical Center – Lebanon, NH

February 6, 2003 Maximum Impact Headache Therapy – Memorial Hospital – North Conway, NH

February 21, 2003 Pharmacologic Treatment of Headache – Cooley-Dickinson Hospital – Northampton, MA

March 1, 2003 Post-traumatic Headaches – Headache Cooperative of New England – Stowe, VT

March 19, 2003 Multiple Sclerosis – In-service for nurses, MENIG unit, Gifford Memorial Hospital – Randolph, VT

March 24, 2003 Differential Diagnosis of Headache – Speare Memorial Hospital – Plymouth, NH

May 20, 2003 Acute and Prophylactic Management of Headache – Grand Rounds, Androscoggin Valley Hospital – Berlin, NH

May 30, 2003 Achieving Success in the Treatment of Migraine – PrimaryCareNet – Norwich, CT

June 6, 2003 Migraine Treatment Acute and Preventative.Medicine Grand Rounds Maine Medical Center – Portland, ME

August 29, 2003 Botulinum Toxin: Focus on Headache – Grand Rounds (Neurology) Dartmouth Hitchcock Medical Center – Lebanon, NH

September 19, 2003 Acute and Preventative Therapy of Migraine. OB/Gyn Grand Rounds Maine Medical Center – Portland, ME

October 18, 2003. Less Common (Primary) Headaches. Headache Cooperative of New England. Boston, MA.

November 19, 2003. Medical Uses of Botulinum Toxin – Neurology in Primary Care DHMC Continuing Medical Education – Concord, NH.

May 4, 2004. Therapy of Migraine. Central Maine Medical Center Grand Rounds. Lewiston, ME.

May 6, 2004. Migraine Diagnosis and Management of Migraine. New Hampshire Society of Systems Pharmacists. Quechee, VT.

July 9, 2004. The Story of Temporal Arteritis – Section of Neurology Grand Rounds, Dartmouth Hitchcock Medical Center – Lebanon, NH

November 6, 2004. Case presentations: Analgesic rebound headache and post-traumatic headache. Headache Cooperative of New England, Colonnade Hotel, Boston, MA.

December 2, 2004. Treatment of Acute Headache. Neurology Grand Rounds, Maine Medical Center, Portland, ME.

January 6, 2005. Acute Migraine Treatment and Prevention. Central Vermont Hospital, Berlin, VT.

February 4, 2005. Acute and Preventative Headache Treatment. Dartmouth Hitchcock Medical Center, Lebanon, NH.

March 5, 2005. Surgical Treatments for Intractable Cluster Headache. Headache Cooperative of New England, Stowe, VT.

April 5, 2005. Migraine Therapy. Bedford Village Inn, Bedford, NH. (Southern NH Medical Center).

May 12, 2005. Giant Cell Arteritis and Other Arteritides. University of Vermont Department of Neurology Grand Rounds, Burlington, VT.

October 20, 2005. Botulinum Toxin Type A in Headache Treatment. University of Michigan, Bedford, NH .

October 28, 2005. Botulinum Toxin in the Treatment of Headaches. Northern New England Neurologic Society, Portsmouth, NH.

November 12, 2005. Headache in the Geriatric Patient. Headache Cooperative of New England, Boston, MA.

November 16, 2005. Acute and Preventative Migraine Treatment, Neurologic Issues In Primary Care. Dartmouth Hitchcock Medical Center. Nashua, NH.

January 6, 2006. Current Migraine Management. Neurology Grand Rounds. Dartmouth Hitchcock Medical Center, Lebanon, NH.

January 23, 2006. Migraine Management Update. NPACE Winter Getaway, Stowe, VT.

March 3, 2006. Testing and Imaging in Headache. Headache Cooperative of New England, Stowe, VT.

March 10, 2006 Headache in the Emergency Room; Treatment of An Acute Headache. Neurology Grand Rounds, Dartmouth Hitchcock Medical Center, Lebanon, NH.

April 9, 2006 Treatment of An Acute Migraine. New York Headache Foundation, New York, New York.

April 29, 2006. Imaging in Chronic Daily Headache. Roundtable Symposium: Strategies for Chronic Daily Headache Prophylaxis. Advanced Studies in Medicine®, Johns Hopkins University School of Medicine. Four Seasons Hotel, Boston, MA.

October 20, 2006. Inpatient Management of Intractable Headache. Neurology Grand Rounds. Dartmouth-Hitchcock Medical Center, Lebanon, NH.

November 2, 2006. Chronic Daily Headache. Headache Cooperative of New England Public Service Seminar presentation at Boston University Medical Center.

November 4, 2006. When and How to Pull the Trigger on Inpatient Management of Headache in the Big House. Headache Cooperative of New England. Boston, MA.

August 6, 2007. Trigeminal Autonomic Cephalgias. Neurology Grand Rounds, Dartmouth-Hitchcock Medical Center. Lebanon, NH

August 11, 2007. Headache treatment in children, pregnancy and lactation, elderly and renal disease. Also; Advanced treatments-inpatient and surgical. Headache Cooperative of New England. Intensive Review of Headache Medicine: Preparation for the UCNS Certification Examination. Sea Crest Resort and Conference Center, North Falmouth, MA.

November 3, 2007. Save Yourself A Headache. Taking Care of #1 Conference. Dartmouth-Hitchcock-Manchester, Catholic Medical Center, Manchester Health Department. Manchester, NH.

November 8, 2007. Chronic Daily Headache. HCNE Public Service Symposium. Boston University Medical Center, Boston, MA.

November 10, 2007. Case Presentations on Headache. HCNE Conference, Colonnade Hotel, Boston, MA.

January 3, 2008. Headache in Women. OB/Gyn Grand Rounds, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

February 29, 2008. Preventative Headache Therapy. HCNE Topnotch/Stowe Conference, Stowe, Vermont.

August 9, 2008. Headache in Special Populations: Children, Pregnancy and Lactation, the Elderly, and Renal Failure, and Advanced Headache Treatment: Inpatient and Procedures. HCNE Review of Headache Medicine, Cambridge, MA.

September 17, 2008. Migraine Pathophysiology: Insights from Clinical Clues. Tufts Dental School, Boston, MA.

September 17, 2008. Migraine Pathophysiology: Insights from Clinical Clues. Pain Clinic, Beth Israel/Deaconess Medical Center, Boston, MA.

September 26, 2008. Migraine Pathophysiology: Insights from Clinical Clues. Neurology Grand Rounds, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

October 23, 2008. Diagnostic Pitfalls in Headache. Neurology Grand Rounds, Maine Medical Center, Portland, Maine.

November 1, 2008. Trigeminal Autonomic Cephalgias. HCNE Conference, Hotel Colonnade, Boston, MA.

March 7, 2009. Occipital and Magnetic Stimulation for Headache. Headache Cooperative of New England, Stowe, Vermont.

May 29, 2009 Headache in the Elderly. Neurology Grand Rounds, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

November 14, 2009. Refractory Headache. HCNE Conference. Hotel Colonnade, Boston, MA.

February 27, 2010.Head and Neck Pain from Cervical Dystonia. Topnotch at Stowe, Vermont. Headache Cooperative of New England.

April 2, 2010. Head and Neck Pain from Cervical Dystonia. Neurology Grand Rounds, Dartmouth-Hitchcock Medical Center. Lebanon, New Hampshire.

November 6, 2010. Trigeminal Autonomic Cephalgias. HCNE. Hotel Colonnade, Boston, MA.

March 4, 2011. Unusual Headache Syndromes. HCNE. Topnotch at Stowe, VT.

July 22, 2011. Thunderclap Headache. Neurology Grand Rounds. Dartmouth-Hitchcock Medical Center, Lebanon NH.

August 19, 2011. Thunderclap Headache. Department of Medicine Grand Rounds. Dartmouth-Hitchcock Medical Center, Lebanon, NH.

September 24, 2011. Trigeminal Autonomic Cephalalgias. Tufts Dental School. Boston, MA.

September 27, 2011. Thunderclap Headache. John R. Graham Headache Center, Faulkner Hospital, Boston, MA.

September 30, 2011. OnabotulinumtoxinA and Chronic Migraine, What the FDA Says and Inpatient Headache Treatment Options. Dartmouth-Hitchcock Medical Center, Lebanon, NH.

October 21, 2011. Thunderclap Headache. Northern New England Neurological Society. Portland, Maine

November 5, 2011. Preventive Headache Therapy. HCNE Boston meeting, Boston, MA.

March 2, 2012. Thunderclap Headache. Headache Cooperative of New England. Stowe, Vermont.

July 13, 2012. Neuro-Bowl. Neurology Grand Rounds, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

September 29, 2012. Migraine Chronification: What it is, why it occurs, and how to treat it. Headache Cooperative of New England. Tufts Dental School, Boston, MA.

March 8, 2013. Botulinum Toxins and Headache. Headache Cooperative of New England (HCNE), Stowe, Vermont.

September 13, 2013 History of Headache Pathophysiology. Tension-Type Headache: “What to say about headache’s Ugly Duckling?” Department of Neurology Grand Rounds, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

January 14, 2014. Headache Disorders. Valley Regional Hospital. Claremont, NH

February 14, 2014. Highlights if the IHC/AHS Meeting 2013 and Trigeminal Autonomic Cephalalgias. Neurology Grand Rounds. Dartmouth-Hitchcock Medical Center, Lebano.n, NH

March 7, 2014. Trigeminal Autonomic Cephalalgias. HCNE, Stowe VT.

March 7, 2014 Botulinum Toxins and Headache. HCNE, Stowe, VT.

July 25, 2014 Publication Ethics: The dos and don’ts. Department of Medicine Grand Rounds. Dartmouth-Hitchcock Medical Center, Lebanon, NH

November 8, 2014. Trigeminal Autonomic Cephalalgias. HCNE, Boston (Tufts Dental School).

December 16, 2014. 2 Cases of Sporadic Hemiplegic Migraine. Beth Israel Deaconess Medical Center monthly headache meeting. Boston, MA.

December 19, 2014 Publication Ethics: The Dos and Don’ts. Department of Neurology Grand Rounds Dartmouth-Hitchcock Medical Center, Lebanon, NH

March 6, 2015. Trigeminal Autonomic Cephalalgias. Headache Cooperative of New England, Stowe, VT (Topnotch at Stowe, HCNE 25^th Anniversary Meeting).

April 1, 2017. My Life in Headache. Lifetime Achievement Award lecture. Headache Cooperative of New England. Stowe Mountain Lodge, Stowe, Vermont.

August 14, 2020 Unusual Cases in Medical Centers and in the Medico-Legal Realm. Neurology Grand Rounds. Dartmouth-Hitchcock Medical Center.

National:

April 6, 1994. The Practicing Physician’s Approach to Migraine, Cluster & Tension Headaches. Miami Pain Center. Dayton, OH

February 28- March 1, 1997. Headache Epidemiology and Pathophysiology. Future Directions of Headache Treatment. Parkview Neurologic Institute, Breckenridge, CO

November 14, 1997 Indomethacin-responsive syndromes. Scottsdale Symposium (AASH). Scottsdale, AZ.

November 15, 1997 Medical Illness/Drug Interaction and Headaches. Scottsdale Symposium (AASH). Scottsdale, AZ.

April 23, 1998 Co-Chair Scientific Platform Session. 5-HT1- Agonists in Migraine. American Academy of Neurology, Minneapolis, MN

July 1998. Neurology Grand Rounds, Cleveland Clinic, Cleveland, OH. Headache Pathogenesis and Therapeutic Opportunities.

August, 1998 Therapeutic Options for Headache Management Neurology Grand Rounds. Mayo Clinic, Rochester, MN

May, 2000 Cluster and other short-lasting headaches – Neurology Ambassadors Program (Headache lecture series developed jointly by the American Headache Society and the American Academy of Neurology). Los Angeles, CA

May 9, 2001 Co-Chair of Scientific Session S27: Novel Therapies and Brain Mechanisms in Migraine and Cluster Headache. American Academy of Neurology Annual Meeting, Philadelphia, PA

June 21, 2001 Headache Drug-drug Interactions. National Headache Foundation, Headache Update 2001. Lake Buena Vista, FL

September 29, 2001 Headache Diagnosis and Testing. Neurology Ambassadors Program (co-sponsored by the American Headache Society and the American Academy of Neurology). Los Angeles, CA

February 16, 2002 Prophylactic Treatment of Migraine. National Headache Foundation.The 15^th Annual Practicing Physician’s Approach to the Difficult Headache Patient. Rancho Mirage, CA

April 16, 2002 Co-chair of Scientific Session on Chronic Daily Headache. American Academy of Neurology Annual Meeting. Denver, CO

June 21, 2002 Co-chair of Platform Session on Acute Migraine Therapy. Annual Meeting of the American Headache Society. Seattle, WA

July 18, 2002 How Sick is Your Patient? Assessing Disability in Headache Treatment. Lake Buena Vista, FL

July 19, 2002 Prophylactic Treatment of Migraine. National Headache Foundation Update 2002. Lake Buena Vista, FL

October 18, 2002. Migraine Treatment. Neurology Ambassador Program. Cleveland, OH

February 14, 2003. Prophylactic Therapy in Migraine. National Headache Foundation. Rancho Mirage, CA

April 2, 2003 Co-chair/moderator (In Dr. Massimo Leone’s absence) Platform Session No. 42 Headache Therapy and Priorities; Migraine Screening Instrument. American Academy of Neurology Annual Meeting. Honolulu, HI

April 5, 2003 Migraine – Understanding the Severity and Impact of Illness. Postgraduate Institute for Medicine. Long Beach, CA

May 17, 2003. Achieving Success in the Treatment of Headache. Primary Care Network. Los Angeles, CA

July 18, 2003. Preventative Treatment of Migraine. National Headache Foundation. Lake Buena Vista, FL

November 1, 2003 Migraine Pathophysiology. PriMed Update. Minneapolis, MN

November 15 and 16, 2003 Botulinum Toxin Injection Technique for Headache Prophylaxis. Scottsdale Headache Symposium (American Headache Society). Scottsdale, AZ

February 12, 2004 Prophylactic Therapy of Headache. National Headache Foundation/17th Annual Practicing Physician’s Approach to the Difficult Headache Patient. Rancho Mirage, CA

April 29, 2004 Co-Chair/moderator with Dr. Massimo Leone Platform Session S63: Headache and Pain: Triptan Mechanisms. Thalamic and Trigeminal Modulation. American Academy of Neurology. San Francisco, CA

July 15, 2004 Anticonvulsants and Their Role in Migraine Prophylaxis. Headache Update 2004. National Headache Foundation, Lake Buena Vista, FL

October 1, 2004 History of the Headache Cooperative of New England. Southeastern Headache Cooperative. Stone Mountain Inn, Atlanta, GA

October 2, 2004 Post-traumatic Headache. Southeastern Headache Cooperative. Stone Mountain Inn, Atlanta, GA.

November 14, 2004. Workshop lecture and demonstration: botulinum toxin in headache treatment. American Headache Society Scottsdale Symposium, Camelback Inn, Scottsdale, AZ.

February 16, 2005. Alternative Therapies in Headache. National Headache Foundation, Rancho Mirage, CA.

April 14, 2005. Scientific Platform Session S69 Co-Chair: Chronic Daily Headache/Medication-overuse Headache. American Academy of Neurology, Miami Beach, Florida.

June 26, 2005. Changes from International Classification of Headache Disorders I and II. American Headache Society Annual Scientific meeting, Philadelphia, PA.

November 19, 2005 Moderator: Important Issues in Headache. American Headache Society Scottsdale Symposium, Scottsdale, AZ

November 19, 2005. Recent Articles That Will Change Your Practice. American Headache Society Scottsdale Symposium, Scottsdale, AZ

November 19, 2005. Neurostimulation and Headache. American Headache Society Scottsdale Symposium, Scottsdale, AZ

November 20, 2005. Headache in the Emergency Room. American Headache Society Scottsdale Symposium, Scottsdale, AZ

April 2, 2006 Headache in Patients with Other Medical Illness. American Academy Of Neurology Annual Meeting, San Diego, CA.

June 22, 2006. Emergency Headache Investigations. American Headache Society Annual Scientific Meeting, Los Angeles, CA.

July 14, 2006. Chronic Daily Headache; Chronic Migraine. National Headache Foundation, Lake Buena Vista, FL.

June 6, 2007. Treatment of Headache in Pregnancy and Lactation, in the Elderly, in Renal Disease; Procedures for Headache; Inpatient Treatment of Headache. American Headache Society Precourse: Review of Headache Medicine. AHS Annual Scientific Meeting, Chicago, IL.

January 31, 2008. Diagnostic Pitfalls in Headache. Lehigh Valley Hospital, Allentown, PA

February 1, 2008. Diagnostic Pitfalls in Headache. Neurology Grand Rounds, Drexel University College of Medicine.

April 18, 2008. Diagnostic Pitfalls in Headache. American Academy of Neurology Annual meeting, Chicago, IL.

April 27, 2008. Cluster Headache and Related Disorders. 20^th Annual Symposium on Treatment of Headaches and Facial Pain. New York Headache Foundation. New York, New York.

June 26, 2008. Preventative Treatment of Tension-type Headache, Cluster Headache, and Other TACs. American Headache Society Pre-Course Review of Headache Medicine. AHS Annual Scientific Meeting, Boston, MA.

June 26, 2008. Advanced Headache Treatments. American Headache Society Pre-Course Review of Headache Medicine. AHS Annual Scientific Meeting, Boston, MA.

April 26, 2009. Preventative Migraine Therapy. 21^st Annual Symposium on Treatment of Headaches and Facial Pain. New York Headache Foundation. New York, New York.

April 19, 2010. Managing a refractory headache patient. 22^nd Annual Symposium on Treatment of Headache and Facial Pain. New York Headache Foundation and Beth Israel Medical Center. New York, New York.

April 28, 2011. Trigeminal Autonomic Cephalalgias. American Academy of Orofacial Pain. Las Vegas, Nevada.

November 7, 2011. Thunderclap Headache. Cleveland Clinic Department of Neurology, Cleveland, Ohio.

November 12, 2011. Chronic Migraine, Medication Overuse Headache Pharmaceutical Protocols (with Dr. Stewart Tepper). American Headache Society Scottsdale Symposium, Scottsdale, AZ.

November 12, 2011. OnabotulinumtoxinA PREEMPT: What the FDA Says. American Headache Society Scottsdale Symposium, Scottsdale, AZ.

January 25, 2012. University of Maryland Department of Neurology. Grand Rounds: Thunderclap Headache. Baltimore, Maryland.

June 22, 2012. Co-Chair/moderator (with Dr. Sheena Aurora) scientific platform session American Headache Society Annual Scientific Meeting, Los Angeles, California.

November 17, 2012. Chronic Migraine: Treatment and Protocols (with Dr. Stewart Tepper/Cleveland Clinic). American Headache Society Scottsdale Symposium, Scottsdale, AZ.

May 10, 2013. Migraine Pathophysiology. American Pain Society Annual Meeting, New Orleans, LA.

May 10, 2013. Acute Migraine Treatment. American Pain Society Annual Meeting, New Orleans, LA.

November 21, 2013. Writing Successfully for Publication. Special Interest Section Symposia 1. American Headache Society Scottsdale Symposim. Scottsdale, AZ. (Session moderator and speaker).

November 23, 2013. Best of Headache 2012-2013. American Headache Society Scottsdale Symposium. Scottsdale, AZ.

November 23, 2013. Plenary 5: Chronic Migraine/Refractory (moderator). American Headache Society Scottsdale Symposium, Scottsdale, AZ.

January 31, 2014. Highlights of 2014 IHC/AHS Meeting. Headache Cooperative of the Pacific (HACOP), Four Seasons Hotel, San Francisco, CA.

June 27, 2014. Harold G. Wolff Award presentation session co-moderator (with Dr. Stephen Silberstein).

56^th Annual Scientific Meeting, American Headache Society, Los Angeles, CA

October 14, 2014 Telementoring session with UCNS fellows (sponsored by AHS): How to get published and case studies in publication ethics.

November 22, 2014 Cases and Highlights from the Headache Literature. American Headache Society, Scottsdale, AZ. (with Drs. David Dodick and Alan Purdy)

April 23, 2015. AAN Highlights in the Field (Headache Medicine). (with Dr. David Dodick). 2015 American Academy of Neurology Annual Meeting, Washington, D.C.

November 2015 Soup, Sandwich and Cephalalgia. Headache Cooperative of New England. Boston, MA.

November 2015 Chronic Daily Headache. American Headache Society Scottsdale Symposium. Scottsdale, AZ

June 2016 Trigeminal Autonomic Cephalalgias. American Academy of Orofacial Pain, Lake Buena Vista, Florida.

October 29, 2016 Acute Migraine Treatment/ Comprehensive Migraine Education Program. American Headache Society. Portland, Oregon

October 29, 2016. Procedural Headache Workshop. Comprehensive Migraine Education Program. American Headache Society. Portland, Oregon.

November 5, 2016. Structural and Biological Basis of Migraine. Comprehensive Migraine Education Program, American Headache Society. Austin, Texas.

November 5, 2016. Acute Migraine Treatment. Comprehensive Migraine Education Program. American Headache Society. Austin, Texas.

November 5, 2016. Procedural Headache Workshop. Comprehensive Migraine Education Program. Austin, Texas.

November 12, 2016. What’s New in the TAC’s? Headache Cooperative of New England. Boston, MA.

November 12, 2016. Cases that confuse (with Professor R. Allan Purdy). Headache Cooperative of New England. Boston, MA.

November 18, 2016. Best of Headache and EHMTIC. American Headache Society, Scottsdale Symposium, Scottsdale, AZ.

November 19, 2016. The Tough Cases and Protocols (with Professor Hans Christoph Diener). American Headache Society Scottsdale Symposium, Scottsdale, AZ.

April 22, 2017 Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop. With Drs. Morris Levin (Director), Andrew Blumenfeld, Matthew Robbins. American Academy of Neurology Annual Meeting, Boston, Massachusetts.

September 5, 2017. Diagnosis of Chronic Migraine. American Headache Society Chronic Migraine Education Program (CMEP). Pain Week, Las Vegas, Nevada.

September 5, 2017. Advances in the Acute Treatment of Chronic Migraine. American Headache Society CMEP. Pain Week, Las Vegas, Nevada.

November 4, 2017 Debate: Neuromodulation is a first line treatment for migraine/cluster. With Dr. Peter McAllister. Headache Cooperative of New England. Boston, MA.

November 16, 2017. Peer Review. American Headache Society. Phoenix, AZ.

November 18, 2017. Best of Headache 2017. American Headache Society. Phoenix, AZ.

January 26, 2018. Best of Headache Literature. (with Professor Morris Levin). Headache Cooperative of the Pacific, Ojai, CA.

January 27, 2018 Does sensory loss exist in trigeminal neuralgia? (with Professor Jes Olesen). Headache Cooperative of the Pacific. Ojai, CA.

April 26, 2018. Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop. With Drs. Morris Levin (Director), Andrew Blumenfeld, Matthew Robbins. American Academy of Neurology Annual Meeting, Los Angeles, CA

November 16, 2018. Optimizing Chances of Academic Publication. American Headache Society, Scottsdale Headache Symposium, Scottsdale, AZ.

November 17, 2018. Our Stars Pick the Top Headache Articles of the Year (moderator). American Headache Society, Scottsdale Headache Symposium, Scottsdale, AZ.

January 26, 2019. A Selection of Best Articles in Headache Medicine. Headache Cooperative of the Pacific, Ojai, CA. (with Dr. Morris Levin).

November 23, 2019. Top 3 Articles in Headache in 2019. Scottsdale Headache Symposium, American Headache Society. Scottsdale, AZ

January 24, 2020. The One Most Important Article from 2019 in Headache and Other Important Articles from 2019 (with Professor Morris Levin). 13^th Annual Meeting of the Headache Cooperative of the Pacific. Ojai Valley Inn, Ojai, CA.

November 21, 2020. Case study: Hemicrania continua. American Headache Society Virtual Scottsdale Meeting.

November 21, 2020. Headache: 2020 Award winning articles in the journal. American Headache Society Virtual Scottsdale Meeting.

January 29, 2021. Is it time to discard the 15 day demarcation between episodic and chronic migraine? Panel discussion withs Drs. Nada Hindeyeh, Morris Levin and David Dodick. Headache Cooperative of the Pacific. Virtual Ojai meeting.

November 21, 2021. Co-moderator (with Dr. Rashmi Halker Singh) “Journal and Other Publications” session. Drs. Amy Gelfand and Allan Purdy presenters. American Headache Society Scottsdale Symposium. Camelback Inn, Scottsdale, AZ.

International:

October 31, 1996. Migraine: Treatment Principles. Mexican National Congress of Neurology. Puerta Vallarta, Mexico.

September 14, 1997 Prevalence and Impact of Headache. XVIth World Congress of Neurology. Buenos Aires, Argentina

May 6, 2000 Post-traumatic Headaches. Sunnyview Health Sciences Center. Toronto, Canada

May 9, 2003 Botulinum Toxin: Therapeutic Uses. Focus on Headache. Department of Neurology, Dalhousie University. Halifax, Nova Scotia, Canada

May 10, 2003. Post-traumatic Headaches. Walter Leslie Lectureship – Atlantic Clinical Neurosciences Society. Halifax, Nova Scotia, Canada

June 10, 2004 Navigating the IHCD II: Trigeminal Autonomic Cephalalgia, and Other New or Changed Primary Headache Diagnoses. American Headache Society. Vancouver, Canada

June 10, 2004 Arnold P. Friedman Award Lecture. Horton’s Disease – Then and Now. American Headache Society, Vancouver, Canad.

May 28, 2005. Headache in Giant Cell Arteritis and Other Arteritides. ANIRCEF (Italian Neurological Association for Research on Headache), Stresa, Italy.

June 28, 2007. Post-traumatic Headache; in How to Diagnose and Manage Difficult Cases. Teaching Course TC6. International Headache Society, Stockholm Sweden.

June 29, 2007. Interesting Cases from Headache Clinics. International Headache Society, Stockholm, Sweden.

November 14, 2008. Chair: “Latest Research” session. 1^st International Headache Summit. Tel Aviv, Israel.

November 14, 2008. Lunch Debate (vs. Professor Alan Rapoport) “Treat migraine early/mild vs. treat late/moderate severe with a triptan. 1^st International Headache Summit. Tel Aviv, Israel.

November 14, 2008. Acute Therapies for Migraines. 1^st International Headache Summit. Tel Aviv, Israel.

May 4, 2011. Treatment of Migraine in the Emergency Department. Tel Aviv Conference on Headache and Pain. Tel Aviv, Israel.

May 5, 2011. Cluster Headaches and other Autonomic Cephalalgias. Tel Aviv Conference on Headache and Pain. Tel Aviv, Israel.

May 11, 2012. When and How to Investigate and Diagnose. International Headache Society Masters School, Guarulhos, SP, Brazil.

May 12, 2012. Migraine: mechanisms. International Headache Society Masters School, Guarulhos, SP, Brazil.

June 27, 2013. Co-Chair (with Dr. Jonathan Gladstone) Teaching Course 5: Tips and Tricks in Headache procedures. Joint meeting American Headache Society/International Headache Society. International Headache Congress (IHC 2013), Boston, MA.

October 10, 2013. History of Headache and Headache Pathophysiology. Brazilian Headache Society Annual Meeting, Goiania, Brazil.

October 10, 2013. Tension-type Headache: What to say about Headache’s Ugly Duckling? Brazilian Headache Society Annual Meeting, Goiania, Brazil.

May 14, 2014.Publication Ethics: The Dos and Don’t’s. Universidade Estadual de Campinas, Campinas, SP, Brazil.

May 15, 2014. Publication Ethics: The Dos and Don’ts. Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

August 11, 2014. Common reasons for manuscripts to get rejected. Instituto Neurologico de Colombia. Medellin, Colombia.

August 12, 2014. Publication Ethics the Dos and Don’ts, and Common reasons manuscripts are rejected.

Universidad EAFIT. Medellin, Colombia.

April 2016. Evidence for neural blockade in headache conditions. With Professor Morris Levin. American Academy of Neurology Annual Meeting. Vancouver, BC, Canada

April 2016. Inpatient protocols for refractory headache. With Professor Morris Levin. American Academy of Neurology Annual Meeting Vancouver, BC, Canada

August 31, 2018. The New Forms of Treatment Available for Refractory Headache. XXXII Congresso Brasileiro de Cefaleia. Porto de Galinhas, Pernambuco, Brazil.

September 1, 2018. Advice on How to Optimize the Chances of Publication in International Journals. . XXXII Congresso Brasileiro de Cefaleia. Porto de Galinhas, Pernambuco, Brazil.

September 1, 2018. Useful Hints on the Acute and Preventive Treatment of a Migraine Patient in the Doctor’s Office. XXXII Congresso Brasileiro de Cefaleia. Porto de Galinhas, Pernambuco, Brazil.

September 5, 2019. The peer review process. International Headache Congress, International Headache Society, Dublin, Ireland. Teaching course.

September 6, 2019. Animal models of migraine are not good enough to predict what will happen in the clinic. International Headache Congress, International Headache Society, Dublin, Ireland. Lunch session debate.

September 7, 2019. Chair Session: Persistent Idiopathic Facial Pain. International Headache Congress, International Headache Society, Dublin, Ireland.

September 8, 2021. Research and Publication Ethics in Headache Medicine. 2021 International Headache Conference, Bermil, Germany (virtual).

BIBLIOGRAPHY:

Journal Articles — Original Articles:

Ward TN, and Scott G. Dihydroergotamine Suppositories in a Headache Clinic. Headache 1991; 465-466.
Stommel EW, Ward TN, Harris RD. MRI Findings in a Case of Ophthalmoplegic Migraine. Headache.1993; 33: 234-37.
Weiner SJ, Ward TN, Ravaris CL. Headache and Electroconvulsive Therapy. Headache.1994; 34:155-59
Cardin A, Conley RN, Swenson R, Thomas GP, and Ward TN. Grand Rounds: Pain and “Swelling” in the Neck Following Surgery for a Congenital Abnormality. Journal of the Neuromusculoskeletal System. 1995; 3:3647.
Schloesser DT, Ward TN, and Williamson PD. Familial Paroxysmal Dystonic Choreoathetosis Revisited. Mov Disord 1996; 3: 317-321.
Ward TN. Management of an Acute Primary Headache. Clinical Neuroscience 1998; 5: 50-54.
Ward TN. Providing relief from headache pain. Postgraduate Medicine 2000; 108:121-128.
Ward TN, Levin M. Headache Caused by a Spinal Cord Stimulator in the Upper Cervical Spine. Headache 2000; 40: 689-691.
Ward TN, Levin M, Phillips JM. Evaluation and Management of Headache in the Emergency Department. Med Clin North Am 2001; 85:971-985.
Ward TN, St. Germain DL, Comi RJ, Cromwell LD. Rathke’s cleft cyst as a secondary cause of headache: a case report. Cephalalgia 2001; 21:921-923.
Ward TN. Headache Disorders in the Elderly. Current Treatment Options in Neurology 2002; 4(5):403-408.
Levin M, Ward TN. Laughing Headache: A Novel Type of Triggered Headache With Response to Divalproex Sodium. Headache 2003; 43: 801-803.
Levin M, Ward, TN, Larson E. Migraine-tic syndrome: a case report of a new headache type. Cephalalgia 2004; 24: 72-73.
Ward TN, Levin M. Diagnosis and pathophysiology of migraine. Expert Rev Neurotherapeutics 2004; 4(3): 383-390.
Ward TN. Medication overuse headache. Prim Care Clin Office Pract. 2004; 31: 369-380.
Levin M, Ward TN. Ophthalmoplegic Migraine. Current Headache Reports 2004; 3: 150-153.
Ward TN, Levin M, Wong RL. Headache Caused by Giant Cell Arteritis. Current Treatment Options in Neurology 2004; 6(6): 499-505.
Peterlin BL, Ward TN, Levin M. Anti-epileptic Drugs in Migraine Prevention. Headache & Pain 2005; 16(1): 18-36.
Ward TN, Levin M. Headache in giant cell arteritis and other arteritides. Neurol Sci 2005; 26 (Suppl. 2): S134-S137.
Levin M, Ward TN. Horton’s Disease: Past and Present. Current Pain Reports 2005; 4: 111-115.
Peterlin BL, Ward TN. Neuropsychiatric Aspects of Migraine. Current Psychiatry Reports 2005; 7: 371-375
Peterlin BL, Levin M, Cohen JA, Ward TN. Secondary cluster headache: a presentation of cerebral venous thrombosis. Cephalalgia 2006; 26: 1022-1024.
Jakubowski M, McAllister PJ, Bajwa ZH, Ward TN, Smith P, Burtsein R. Exploding vs. imploding Headache in migraine prophylaxis with Botulinum Toxin A. Pain 2006; 125(3): 286-295.
Peterlin BL, Ward TN, Lidicker J, Levin M. A Retrospective, Comparative Study on the Frequency Of Abuse in Migraine and Chronic Daily Headache. Headache 2007; 47: 397-401.
Fenstermacher N, Levin M, Ward T. Pharmacologic prevention of migraine. BMJ 2011; 342:540-543
Smitherman TA, Ward TN. Psychosocial Factors of Relevance to Sex and Gender Studies in Headache. Headache 2011;51: 923-931
Peterlin BL, Gupta S, Ward TN, MacGregor A. Sex Matters: Evaluating Sex and Gender in Migraine and Headache Research (Editorial). Headache 2011; 51(6): 839-842.
Purdy RA, Ward TN. Dangerous and Thunderclap Headaches. Headache 2012; 52 (Suppl 2): 56-59.
Peterlin BL, Tietjen GE, Gower BA, Ward TN, Tepper SJ, White LW, Dash PD, Hammond ER, Haythornwaite JA. Ictal Adiponectin Levels in Episodic Migraineurs: A Randomized Pilot Trial. Headache 2013; 53: 474-490.
Chai NC, Gelaye B, Dash PD, Gower BA, White LW, Ward TN, Scher AI, Peterlin, BL Ictal Adipokines are associated with pain severity and treatment response in episodic migraine. Neurology 2015; 84: 1409-1418.
Ward TN. Does the presence of aura inform us regarding migraine severity and response to treatment? Neurology 2015;84:1828-1829 (editorial).
Nye BL, Ward TN. Clinic and Emergency Room Evaluation and Testing of Headache. Headache 2015; 55: 1301-1308.
Ward TN. Peer review: Toward improving the integrity of the process. Neurology 2015; 85 (20): 1734-1756 (editorial).
Roberts J, Ward TN, Taylor FR. Redundancy in the Headache Literature. What Constitutes Unethical Practice. Headache 2017; 57(5): 693-696 (editorial).
Louter MA, Ward TN, Terwindt GM. Chronic Headache. What’s in a name? Neurology 2017; 89: 224-225 (editorial).
de Ru, JA, Ward TN, Roberts JL. Veracity in the Review Process. Headache 2019; 59: 1429-1433.
Ward TN. “Hello, I Must Be Going.” Headache 2020; 60(10): 2117 (editorial).
Ward TN, Green AL. Preface: Update in Headache. Semin Neurol 2022; 42:404-405

Letters to the Editor:

Ward TN, Bernat JL, and Goldstein AS. Occlusion of the Anterior Choroidal Artery. Journal of Neurology, Neurosurgery and Psychiatry. 1984; 47:1048-1049.
Ward TN, Anterior Choroidal Artery Occlusion. Letter to the Editor, Archives of Neurology 1985; 5:424.
Ward TN, Smith EB, and Reeves AG. Dimethylglycine and Reduction of Mortality in Penicillin-Induced Seizures. Annals of Neurology. 1985; 17:213.
Stommel EW, Ward TN, and Harris RD. Ophthalmoplegic Migraine or Tolosa-Hunt Syndrome? Headache 1994; 34:177

Abstracts:

Presented at Regional Meetings:

Case of Delayed Encephalopathy Secondary to Acute Fentanyl Intoxication. Dahle D, Caller TA, Ward TN. Neuroscience Day, Dartmouth College, Hanover NH. March 16, 2012.only those not containing data not yet published in complete form

Presented at National Meetings :

Patient-reported Tablet Utilization of Zolmitriptan and Sumatriptan. S. Tepper, T Ward, C. Maurer. Shown at the 40th Annual Meeting of the American Association for the Study of Headache. San Francisco,CA. June, 1998.

Treatment of Chronic Daily Headache with Intravenous Chlorpromazine. A Ashkenazi, M Levin, TN Ward. Abstract S135.44th Annual Scientific Meeting of the American Headache Society. Seattle, Washington. June 2002.

Zolmitriptan 2.5mg Orally Disintegrating Tablet Achieves High Pain-Free Rates in the Acute Treatment of Migraine — Results of a Randomized, Double-blind, Placebo-Controlled Study. E Loder, S Abu-Shakra, T Ward, A Rapoport. American Academy of Neurology Annual Meeting, Honolulu, Hawaii, April 2003.

Thirty-minute Efficacy of Zolmitriptan Oral Formulations in the Treatment of Moderate to Severe Migraine: Results of a Pooled Data Analysis. Ward T, Dowson A, Charlesworth B, Hughes J, Syrett N. 45th Annual Scientific Meeting of the American Headache Society. Chicago, Illinois. June 2003.

Thirty-minute Efficacy of Zolmitriptan Oral Formulations in the Treatment of Moderate to Severe migraine: Results of a Pooled Data Analysis. Headache Update 2003. National Headache Foundation. July 15-19, 2003. Grand Floridian Resort, Lake Buena Vista, Florida.

Treatment satisfaction with a new single-tablet formulation of sumatriptan formulated with RT Technology™ and naproxen sodium. Cady R, Rothrock J, Blumenthal H, Ward T, Ames M, Burch S. American Academy of Neurology Annual Meeting, San Diego, CA, April 4, 2006.

Presented at International Meetings :

Zolmitriptan (‘Zomig’): Rapid Onset of Migraine Headache Relief. AM Rapoport, T Ward, DA Katz, FD Sheftell. Shown at the International Headache Society Meeting, Amsterdam, The Netherlands. June, 1997.

Pericranial Injections of Two Doses of Botulinum Toxin Type A (Botox®) in the Prophylactic Treatment of Headache. Ward TN et al. 4^th International Conference on Botulinum Toxin, Orlando, FL. October 1999.

Hypnic Headache Presenting with Typical Migraine Aura. Levin M, Ward TN. 12^th Congress of the International Headache Society. Kyoto, Japan October 9-12, 2005.

Review of Diagnoses of 50 Consecutive Patients with Chronic Daily Headache using the ICHD-II. Levin M, Peterlin BL, Ward TN. 12^th Congress of the International Headache Society. Kyoto, Japan. October 9-12, 2005

OnabotulinumA for Treatment of Chronic Migraine: PREEMPT 1 Trial, Double-Blind Phase. Aurora SK, Schim JD, Cutrer FM, Ward TN, Blumenfeld A, Lay C, Patel S, Lei X, Turkel CC. 14^th Congress of the International Headache Society. Philadelphia, Pennsylvania. September 10-13, 2009.

A novel program of peer review training and collaborative peer review. Loder E, Roberts J, Rizzoli P, Burch R, Ward TN. 16^th Congress of the International Headache Society. Boston, Massachusetts. June 27-30, 2013.

Book Chapters:

Ward TN. 1996 Headache in Cerebrovascular Disease. In: Samuels MA and Freske S (eds): Office Practice of Neurology, Churchill Livingstone; Chapter 211:1141-1144.
Ward TN. 1999. The Man with the Evolving Headache. In: Rapoport AM, Sheftell FD, Purdy RA (eds): Advanced Therapy of Headache. BC Decker Inc. Hamilton, Chapter 27:167-170.
Ward TN. 2000. Headache Therapy. In: Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW (eds): Melmon and Morrelli’s Clinical Pharmacology and Therapeutics. 4th Ed. McGraw-Hill, Inc. New York, Chapter 7:401-410.
Ward TN. 2003. Headache (with Levin M). Ataxia. Demyelinating Disease. In: Levin M, Choe JM (eds). Neurology Clinical Case Studies: Oral Board Exam Review. Anadem Publishing. Columbus. Chapters 2: 13-27; 5: 55-65; and 9: 113-123.
Ward TN, Levin M. 2003 Facial Pain. In: Warfield C, Bajwa Z (eds): Principles and Practice of Pain Medicine. 2^nd McGraw-Hill Inc. New York, Chapter 25: 246-251.
Ward TN, Levin M. 2004 Posttraumatic Headache. In: Silver J, Yudofsky SC, McAllister TW (eds): Textbook of Traumatic Brain Injury. 2nd Ed. American Psychiatric Publishing, Inc. Washington, Chapter 21: 385-391.
Ward TN. 2005. Poison a Headache? In: Purdy RA, Rapoport AM, Sheftell FD, Tepper SJ (eds): Advanced Therapy of Headache. 2^nd BC Decker Inc. Hamilton, Chapter 50: 275-278.
Sandrini G, Ward TN. 2006. Acute Treatment of Cluster Headaches. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds): The Headaches. 3^rd Lippincott Williams & Wilkins. Philadelphia. Chapter 25: 803-807.
Arle JE, Ward TN. 2006. Current Management of Cervical Dystonia. In: Schmidek HH, Roberts DW (eds): Schmidek & Sweet’s Operative Neurosurgical Techniques: Indications, Methods, and Results. 5^th Saunders Elsevier. Philadelphia. Chapter 105:1491-1497.
Ward TN. 2006. Cluster Headache and Related Headaches. In: Levin M, Ward TN (eds): Head, Neck and Facial Pain. A Case-based Handbook of Diagnosis, Management, and Prognosis. Anadem Publishing, Columbus, Ohio. Chapter 3: 19-23.
Ward TN 2006. Headache Evaluation and Treatment. In: Holmes GL, Cohen JA, Levin M (eds): Educational Review Manual In Neurology. Castle Connolly Graduate Medical Publishing, New York, New York. Chapter 26: 769-790.
Ward TN 2008. Treatment of Intractable Headache and Special Populations. In: Levin M (ed.): Comprehensive Review of Headache Medicine. Oxford University Press. Chapter 15.
Ward TN 2008. Inpatient Headache Treatment. In: Levin M (ed.): Comprehensive Review of Headache Medicine. Oxford University Press. Chapter 16.
Ward TN 2008. Procedures for Headache. In: Levin M (ed.): Comprehensive Review of Headache Medicine. Oxford University Press. Chapter 18.
Ward TN 2008. Headache Evaluation and Treatment. In: Levin M, Holmes GL, Cohen JA (eds): Educational Review Manual in Neurology (2^nd Edition). Castle Connolly Graduate Medical Publishing, New York, New York. Chapter 26: 883-907
Ward TN 2010. History taking and examination of patients with Refractory Headache. In: Schulman EA, Levin M, Lake III, AE, Loder E (eds.): Refractory Migraine. Mechanisms and Management. Oxford University Press, Oxford. Chapter 5: 58-68.
Levin M, Ward TN. 2011. Posttraumatic Headache. In: Silver JN, McAllister TW, Yudofsky SC. Textbook of Traumatic Brain Injury 2^nd American Psychiatric Publishing, Inc. Washington. Chapter 21: 343-350.
Ward TN 2012. Migraine Diagnosis and Pathophysiology. Continuum Lifelong Learning in Neurology 2012; 18(4): 753-763.
Grant JA, Kim RJ, Nye BL, Ward TN. 2017. Headache and Systemic Disorders. In: Ravishankar K, Evans RW, Wang, S-J (eds): Modern Day Management of Headache. Questions and Answers. Jaypee Brothers Medical Publishers, New Delhi. Chapter 25: 333-344.

Books

Levin M, Ward TN (eds).2006. Head, Neck and Facial Pain. A Case-based Handbook of Diagnosis, Management, and Prognosis. Anadem Publishing. Columbus, Ohio.
Levin M, Ward TN. 2017. Understanding Your Migraines. Oxford University Press, New York, New York.

Other

Liou J, Grudem J, Ward TN. Resident and Fellow Section. Teaching Case: Severe Headaches in an Elderly Patient. Headache 2007; 47(1): 153-155.
Levin M, Ward T (guest editors): Proceedings of the 25th Anniversary Symposium of the New England Center for Headache, Stamford, CT. Headache 2007; 47(Suppl 1): S1-S63.
Ward TN. My Favorite Article. Drug-Induced Refractory Headache. Headache 2008; 48: 728- 729.
Ward TN, Allen WR. Case 3: The Steroid Complication. Headache 2008; 48(6): 866-870.
Hosley CM, Ward TN. Teaching Case – Headache in the Emergency Room: A Review. Headache 2008; 48(6): 988-990.
Vargas B, Ward TN. Teaching Case: Ophthalmoplegic Migraine. Headache 2008; 48 (9): 1396-1398.
Ward TN. Transcranial Magnetic Stimulation (editorial). Headache Currents. Headache 2010; 50(10): 1629.
Caller T, Ward TN. Teaching Case: Equine Cephalalgia. Headache 2011; 51(4): 629-631.
Ward TN. Statement of Concern. Headache 2014; 54(4): 599-600.
Ward TN. Statement of Concern. Headache 2017; 57(5): 697-698.

Updated by: Thomas N. Ward MD
February 5, 2023